Home › Teva shares slide on generic Copaxone fears
 

Keywords :   


Teva shares slide on generic Copaxone fears

2015-04-20 00:21:19| Biotech - Topix.net

Teva Pharmaceutical Industries shares slid five percent on Sunday after U.S. regulators approved a generic version of its top-selling multiple sclerosis drug and amid reports it was mulling a bid for rival Mylan. Teva's Tel Aviv shares fell to 249.80 shekels late on Sunday, the first day of trading since both news hit the market on Thursday after Israel's market closed for the weekend.

Tags: shares slide generic fears

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Lakamps research aims to use cattle genetics and microbiome information to make performance predictions
03.07Keep livestock safe during hurricane season with an emergency plan
03.07Making the most of forage resources
03.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Forecast Discussion Number 17
02.07Hurricane Beryl Forecast Advisory Number 17
02.07Ansell Completes Acquisition of Kimberly-Clarks PPE Business
More »